MST1 is a key regulator of beta cell apoptosis and dysfunction in diabetes
Amin Ardestani(Hull York Medical School), Kathrin Maedler(University of Bremen), Zahra Azizi(Universität Hamburg), Wufan Tao(Fudan University), Federico Paroni(University of Bremen), José Oberholzer(University Hospital of Zurich), Ting Yuan(Goethe University Frankfurt), Vrushali Khobragade(University of Bremen), Supreet Kaur(The University of Texas at San Antonio Health Science Center), François Pattou(Inserm), Julie Kerr-Conte(Inserm), Thomas Frogne(Novo Nordisk (Denmark))
Cited by 203
Related Papers
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
|Signal Transduction and Targeted Therapy|2021|1.7k
Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates
|Nature Materials|2015|895
New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis
|Redox Biology|2018|753
Long-term glycemic control using polymer-encapsulated human stem cell–derived beta cells in immune-competent mice
|Nature Medicine|2016|708
Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates
|Nature Biotechnology|2016|551